Note: This original, research-based article is for informational purposes only and is not legal, insurance, or investment advice.
Third-party litigation funding used to sound like something invented by a law-school professor after too much coffee: investors put money into lawsuits and may receive a share of a settlement or judgment if the case succeeds. Today, it is a major policy issue touching insurance, corporate risk, consumer protection, intellectual property, and access to justice.
That tension was front and center when the U.S. House Committee on Oversight and Accountability held its September 13, 2023 hearing, “Unsuitable Litigation: Oversight of Third-Party Litigation Funding.” The hearing examined whether outside funders can quietly shape lawsuits, influence settlements, pursue policy goals, or create conflicts that courts and opposing parties cannot see.
For independent insurance agents and risk professionals, the issue matters because litigation funding is not merely a courtroom trend. It can affect claim duration, settlement pressure, defense costs, loss reserves, liability pricing, and the increasingly mysterious path from “we disagree” to “why is everyone in this conference room ordering takeout at 10 p.m.?”
The central question is not whether all litigation funding is good or bad. It is whether the legal system has enough visibility and guardrails to ensure that the person bringing the claim, rather than an undisclosed investor, remains in charge.
What Is Third-Party Litigation Funding?
Third-party litigation funding, often shortened to TPLF, is a financial arrangement in which a person or company that is not a party to a lawsuit provides funding to a litigant or law firm in exchange for a potential share of the recovery. The arrangement is generally nonrecourse, meaning the funded party typically does not repay the funder if the case loses.
There are two broad categories:
- Commercial litigation funding: Often used by businesses, law firms, insolvency estates, or companies pursuing high-value disputes involving contracts, patents, trade secrets, antitrust allegations, or other complex claims.
- Consumer litigation funding: Often associated with individuals who need money while waiting for a personal injury, employment, medical liability, or other civil claim to resolve.
At first glance, the model appears straightforward. A claimant has a potentially valuable case but lacks the money, cash flow, or appetite to spend years financing legal fees. A funder provides capital. The lawsuit proceeds. If the claimant wins, the funder receives an agreed return.
But lawsuits are not stock certificates with better wigs. They involve confidential evidence, legal strategy, client decision-making, ethical duties, and sometimes public policy disputes. The moment an outside investor has a financial interest in the outcome, courts and policymakers begin asking whether the arrangement should be disclosed and whether limits are needed.
Why the House Oversight Hearing Drew Attention
The House Oversight hearing brought together witnesses with sharply different perspectives. The witness list included legal scholar Maya Steinitz, industry representatives, a Johnson & Johnson legal executive, and Washington University law professor Kathleen Clark. The range of witnesses reflected the fact that litigation funding is not a simple left-versus-right or plaintiff-versus-defendant issue.
Committee members and critics of TPLF raised concerns about undisclosed activist funding, foreign investment, funder influence over litigation decisions, and the possibility that investors could extend cases or discourage settlements in pursuit of higher returns. Supporters and academic observers stressed that litigation finance can help individuals, startups, small businesses, and other under-resourced parties pursue meritorious claims against wealthier opponents.
Professor Steinitz described litigation funding as a tool that can be beneficial or harmful depending on how it is used and regulated. That may sound almost painfully reasonable for Washington, but it captures the debate well: funding can improve access to courts while also creating risks when the money trail is hidden.
The hearing therefore mattered less because it produced an instant legislative fix and more because it moved litigation finance into a broader conversation about transparency, ethics, national security, and civil justice reform.
The Core Debate: Access to Justice Versus Hidden Influence
How Litigation Funding Can Expand Access to Justice
Supporters argue that lawsuits can be expensive enough to make even a strong claim feel theoretical. A small company may have a valid claim against a much larger competitor but lack the cash to pay experts, lawyers, discovery vendors, and years of legal bills. An individual claimant may face medical bills, lost income, and the uncomfortable reality that rent does not pause for litigation.
Funding can reduce that financial imbalance. It may allow a claimant to hire specialized counsel, withstand delay tactics, or avoid accepting a low settlement simply because money is running out. In commercial cases, it can also help companies treat legal claims as financial assets rather than budget black holes.
This is the strongest argument for litigation finance: a legal right is not especially useful when only the wealthiest party can afford to enforce it.
Why Transparency Has Become the Main Policy Issue
Critics do not necessarily argue that every funding arrangement should be prohibited. Their main concern is that undisclosed financing can hide conflicts of interest and change the economic incentives surrounding a case.
For example, a funder may prefer a claimant to keep fighting because a larger verdict could produce a larger return. The claimant, however, may prefer to settle and move on with life. Those interests can align, but they can also collide like shopping carts in a crowded warehouse aisle.
Disclosure supporters argue that judges need to know who has a financial interest in litigation so they can identify conflicts, manage discovery, protect confidential information, and assess whether the funder is exerting improper control. The Government Accountability Office has noted that there is no nationwide federal requirement for litigants to disclose funding agreements, although some courts have required disclosures in particular cases.
Concerns About Foreign Funding and Sensitive Information
Foreign investment has become another major concern, particularly in cases involving intellectual property, technology, defense-related industries, trade secrets, or strategic infrastructure. Critics worry that a foreign-linked funder could gain indirect insight into sensitive business information through litigation financing arrangements.
That concern does not mean every foreign investor is acting improperly. It does mean courts and lawmakers are increasingly examining whether funder identity, ownership, and access to protected information should be disclosed more clearly. The House Oversight Committee continued pressing for greater transparency after the hearing, including requests for the Judicial Conference to examine nationwide disclosure practices.
Why Insurers and Independent Agents Should Pay Attention
For insurers, litigation funding can complicate the normal rhythm of claims resolution. A funded claimant may have more resources to pursue discovery, retain experts, and continue litigation. Defense counsel may need to consider whether an undisclosed funder has influenced settlement posture or holds an interest in confidential materials.
That does not mean a funded claim is automatically inflated, frivolous, or impossible to settle. It does mean that the financial ecosystem around a claim may be more complex than it appears from the caption on the complaint.
Independent agents can help commercial clients understand the broader risk environment. Coverage discussions should not stop at “Do you have general liability?” Businesses also need to understand litigation management, document retention, cyber controls, contractual risk transfer, employment practices, product liability exposure, and the rising cost of prolonged disputes.
What Sensible Third-Party Litigation Funding Regulation Could Look Like
A useful reform framework does not have to choose between a total ban and a regulatory shrug. Several practical safeguards could address the most serious concerns while preserving funding for legitimate claims.
1. Require Targeted Disclosure
Courts could require litigants to disclose the identity of funders with a financial interest in the case, particularly in class actions, multidistrict litigation, mass torts, and high-value commercial disputes. The goal would be transparency, not unnecessary public exposure of every strategic detail.
2. Protect Client Control
Funding agreements should make clear that lawyers owe duties to their clients, not investors. Funders should not control legal strategy, settlement decisions, or whether a client accepts an offer.
3. Limit Access to Protected Materials
Funding may require due diligence, but that does not mean investors should have unrestricted access to privileged documents, trade secrets, or confidential settlement discussions. Courts can use protective orders and carefully tailored disclosure rules to reduce that risk.
4. Address Consumer Funding Costs
Consumer litigation funding deserves special attention because individuals facing financial stress may accept expensive agreements without fully understanding the repayment structure. Clear disclosures, fee limits, cancellation rights, and plain-language contracts can help prevent a legal advance from becoming a financial ambush.
5. Create Consistent Rules Rather Than a Patchwork
Different state rules and local court practices create uncertainty for plaintiffs, defendants, insurers, law firms, and funders. A thoughtful national approach could provide more predictability while allowing courts to tailor disclosure requirements when a case presents unusual risks.
What Has Changed Since the House Oversight Hearing?
The 2023 hearing did not end the debate. It helped launch a continuing policy push around disclosure and investor influence. In 2024, House Oversight leadership urged the Judicial Conference to consider nationwide transparency standards, while lawmakers also continued examining the role of funding in intellectual property and innovation disputes.
In 2026, Senate Judiciary Committee Chairman Chuck Grassley and several Senate colleagues introduced the Litigation Funding Transparency Act, a proposal focused on disclosure in mass tort and class action cases. The bill would also seek to restrict funder influence over litigation strategy and settlement negotiations, while limiting access to protected documents.
State action is moving even faster. On June 23, 2026, North Carolina became the first state reported to enact a broad ban on third-party litigation financing through its Prohibit Litigation Investments Act. The move underscores how quickly the policy conversation has shifted from “Should courts disclose funding?” to “Should some forms of funding be restricted altogether?”
Meanwhile, federal judges and court policymakers continue studying whether existing rules are enough. The Federal Judicial Center has long identified litigation funding as a subject involving ethical questions, discovery disputes, and case-management challenges for judges.
Extended Field Experience: How Litigation Funding Shows Up in Real Life
The following composite examples reflect recurring practical issues discussed in legal, insurance, regulatory, and courtroom conversations. They are illustrative rather than descriptions of any single case.
A Small Business With a Strong Claim but a Thin Budget
Imagine a regional manufacturer that believes a larger competitor copied a patented production process. The manufacturer may have engineers, documents, and a plausible case, but patent litigation can demand years of attorney time, expert testimony, electronic discovery, and technical analysis. The company’s leadership faces an unpleasant choice: pursue the claim and strain operations, or walk away from a potentially valuable right.
A litigation funder may offer capital in exchange for a share of the recovery. For the business, that can turn a claim from an expensive gamble into a manageable project. For the funder, it is an investment with potentially large upside and a very real chance of losing everything. For the insurer, it may mean a dispute that once looked likely to settle early now has the resources to continue through discovery and trial.
A Claimant Facing Financial Pressure
Now consider an injured claimant who cannot work while a lawsuit moves slowly through the civil justice system. A funding advance may help cover groceries, transportation, or rent. That relief can be meaningful. But the claimant also needs to understand the financial trade-off. A nonrecourse advance may not require repayment after a loss, yet the repayment amount after a successful settlement can be substantial depending on the agreement.
The practical lesson is simple: access to funding should come with clear, plain-language information. People should know what they are giving up, how repayment works, and whether they have alternatives. Nobody should need a decoder ring and a finance degree to understand a funding contract.
An Insurer Trying to Evaluate Settlement Risk
From an insurer’s perspective, the presence of third-party funding can introduce uncertainty. The carrier may be evaluating a reasonable settlement offer based on liability facts, damages, policy limits, defense costs, and business considerations. But if an outside funder expects a high return, the economic pressure may point toward continued litigation.
That does not mean the claimant lacks control or that settlement is impossible. It means the claims team may need a fuller picture of the forces shaping negotiations. Transparent disclosure can help the court and the parties identify conflicts early, protect confidential information, and avoid surprises after months of expensive litigation.
A Law Firm Balancing Ethics and Financing
Law firms may use portfolio funding to support multiple cases, invest in technology, cover litigation expenses, or stabilize cash flow. Used responsibly, funding can help firms take on complex matters and compete with larger practices. But the arrangement must be structured carefully. Lawyers cannot allow an investor’s financial preferences to override professional judgment or client objectives.
That is why ethics rules, engagement letters, conflict checks, confidentiality protections, and clear communication matter so much. Litigation finance may be modern, but the core legal principle is ancient: the client’s interests come first.
What Businesses Can Do Before Litigation Arrives
Businesses do not need to wait for a lawsuit to think about litigation funding risk. Strong preparation can reduce vulnerability regardless of whether a claimant is funded. Maintain contracts, preserve records, protect trade secrets, document safety procedures, update employment policies, manage vendor obligations, and review insurance coverage regularly.
When a significant claim appears, involve experienced legal counsel, insurance professionals, and internal decision-makers early. The best litigation strategy is rarely improvised after the complaint arrives. By then, the coffee is cold, the deadlines are real, and everyone suddenly discovers that “we should have documented that” is not a legal defense.
Conclusion
Third-party litigation funding is likely to remain part of the American civil justice system, but the rules surrounding it are changing quickly. The House Oversight Committee hearing put the spotlight on a difficult question: how can policymakers preserve access to justice without allowing hidden investors to influence lawsuits, settlements, confidential information, or public policy from behind the curtain?
The most durable answer is likely to involve transparency, client-control protections, consumer safeguards, ethical oversight, and clear rules for courts. For insurers, independent agents, businesses, claimants, and law firms, the message is the same: litigation funding is no longer a niche issue. It is part of the broader risk conversation, and pretending otherwise is not a strategy.
